ISSN: 2451-9456

Journal Home

Journal Guideline

Cell Chemical Biology Q1 Unclaimed

Elsevier Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cell Chemical Biology is a journal indexed in SJR in Molecular Biology and Biochemistry with an H index of 206. It has an SJR impact factor of 2,584 and it has a best quartile of Q1. It has an SJR impact factor of 2,584.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Biochemistry (Q1) Clinical Biochemistry (Q1) Clinical Biochemistry (Q1) Drug Discovery (Q1) Molecular Biology (Q1) Molecular Medicine (Q1) Pharmacology (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

2,584

SJR Impact factor

206

H Index

163

Total Docs (Last Year)

476

Total Docs (3 years)

9370

Total Refs

3228

Total Cites (3 years)

423

Citable Docs (3 years)

5.59

Cites/Doc (2 years)

57.48

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Cell Research Q1
Molecular Cell Q1
Cell Host and Microbe Q1
Annual Review of Plant Biology Q1
Journal of Hematology and Oncology Q1

Compare this journals

Aims and Scope

Best articles by citations

GNF-2 Inhibits Dengue Virus by Targeting Abl Kinases and the Viral E Protein

Small-Molecule Target Engagement in Cells

Unique Binding Specificities of Proteins toward Isomeric Asparagine-Linked Glycans

Quinoline Derivatives Kill Mycobacterium tuberculosis by Activating Glutamate Kinase

A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling

Small-Molecule-Targeting Hairpin Loop of hTERT Promoter G-Quadruplex Induces Cancer Cell Death

Emerging Opportunities for Target Discovery in Rare Cancers

AKAP95 Organizes a Nuclear Microdomain to Control Local cAMP for Regulating Nuclear PKA

Combining Stage Specificity and Metabolomic Profiling to Advance Antimalarial Drug Discovery

Inhibition of Glucose Transporters and Glutaminase Synergistically Impairs Tumor Cell Growth

CBP/p300 Bromodomain Mediates Amyloid Formation

CBP/p300 Bromodomains Regulate Amyloid-like Protein Aggregation upon Aberrant Lysine Acetylation

SHOW MORE ARTICLES

Targeting Pim Kinases and DAPK3 to Control Hypertension

Identification of the Nicotinamide Salvage Pathway as a New Toxification Route for Antimetabolites

Formation of the Alarmones Diadenosine Triphosphate and Tetraphosphate by Ubiquitin- and Ubiquitin-like-Activating Enzymes

One Ring to Fight Them All: The Sulfazecin Story

Allosteric Inhibition of Ubiquitin-like Modifications by a Class of Inhibitor of SUMO-Activating Enzyme

Glucose Metabolism and Oxygen Availability Govern Reactivation of the Latent Human Retrovirus HTLV-1

Allosteric Regulation of Oligomerization by a B12 Trafficking G-Protein Is Corrupted in Methylmalonic Aciduria

Quantitative Interactome Proteomics Reveals a Molecular Basis for ATF6-Dependent Regulation of a Destabilized Amyloidogenic Protein

HTiP: High-Throughput Immunomodulator Phenotypic Screening Platform to Reveal IAP Antagonists as Anti-cancer Immune Enhancers

Management of Hsp90-Dependent Protein Folding by Small Molecules Targeting the Aha1 Co-Chaperone

Cutting Choline with Radical Scissors

Subcellular Hsp70 Inhibitors Promote Cancer Cell Death via Different Mechanisms